Аннотация:
Aim. To prove that diagnostic algorithm based on additional measurement of serum C-reactive protein (CRP) for administration of systemic antibacterial therapy (ABT) to patients with suspected community-acquired pneumonia (CAP) and concomitant chronic heart failure (CHF) does not influence outcomes of disease. Materials and methods. This open, single-center, randomized, prospective, non-inferiority study included 160 adult patients with documented functional class II–IV CHF who had been admitted with a preliminary diagnosis of non-severe CAP. Patients were randomized at 1:1 to two groups; group 1 – with additional measurement of CRP (n=80) and group 2 – with the use of routine diagnostic methods (n=80). In group 1, systemic ABT was administered only when serum CRP was >28.5 mg/l (threshold level of the biomarker calculated at the previous stage of the study); group 2 received a standard treatment. Non-inferiority test result for both algorithms was evaluated by the number of patients wi
Ключевые слова:
Biomarkers; C-reactive protein; Chronic heart failure; Community-acquired pneumonia
antiinfective agent; C reactive protein; controlled study; heart failure; human; pneumonia; prospective study; randomized controlled trial; Anti-Bacterial Agents; C-Reactive Protein; Heart Failure; Humans; Pneumonia; Prospective Studies
Бобyлев А. А.
Рачина С. А. Светлана Александровна 1974-
Авдеев С. Н. Сергей Николаевич 1968-
Козлов Р. С.
Младов В. В.
Bobylev A. A.
Rachina S. A. Svetlana Aleksandrovna 1974-
Avdeev S. N. Sergej Nikolaevich 1968-
Kozlov R. S.
Mladov V. V.
C-reactive protein evaluation in community-acquired pneumonia with comorbid chronic heart failure as criterion of antibiotic prescription [Определение C-реактивного белка при внебольничной пневмонии на фоне хронической сердечной недостаточности как критерий назначения антибактериальной терапии]
C-reactive protein evaluation in community-acquired pneumonia with comorbid chronic heart failure as criterion of antibiotic prescription...
Текст визуальный непосредственный
Кардиология
Общество специалистов по сердечной недостаточности
Т. 59 С. 40-46
2019
Статья
Biomarkers C-reactive protein Chronic heart failure Community-acquired pneumonia
antiinfective agent C reactive protein controlled study heart failure human pneumonia prospective study randomized controlled trial Anti-Bacterial Agents C-Reactive Protein Heart Failure Humans Pneumonia Prospective Studies
Aim. To prove that diagnostic algorithm based on additional measurement of serum C-reactive protein (CRP) for administration of systemic antibacterial therapy (ABT) to patients with suspected community-acquired pneumonia (CAP) and concomitant chronic heart failure (CHF) does not influence outcomes of disease. Materials and methods. This open, single-center, randomized, prospective, non-inferiority study included 160 adult patients with documented functional class II–IV CHF who had been admitted with a preliminary diagnosis of non-severe CAP. Patients were randomized at 1:1 to two groups; group 1 – with additional measurement of CRP (n=80) and group 2 – with the use of routine diagnostic methods (n=80). In group 1, systemic ABT was administered only when serum CRP was >28.5 mg/l (threshold level of the biomarker calculated at the previous stage of the study); group 2 received a standard treatment. Non-inferiority test result for both algorithms was evaluated by the number of patients wi